OA01.05 Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up

Autor: Cuppens, K., Baas, P., Wiesweg, M., Du Pont, B., Ploenes, T., Theegarten, D., Aigner, C., Hartemink, K., Maes, B., Pat, K., Schuler, M.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S9-S9
Databáze: ScienceDirect